latest news releases from the newsroom
Teen Pop Group "TGK" Set To Release Highly Anticipated Album
LOS ANGELES, Dec. 1, 2004 (PRIMEZONE) -- KidSational, Inc. (Pink Sheets:KDSC) announces that the Teen Pop Group, TGK is set to release their debut untitled album during the First Quarter of 2005 on KidSational Records. The first single "HOTT" is slated to be officially released in mid-January and will garner early airplay at mid-market radio stations on both the East and West Coasts.
Software International Inc.
Knobias Initiates Research Coverage of Software International, Inc.
SOMERSET, N.J., Dec. 1, 2004 (PRIMEZONE) -- Knobias.com, L.L.C. and Software International, Inc. (Pink Sheets:SWII) announced today that the Knobias Research Report and an up close interview with CEO Suneel Sawant & CTO Ninad Panse would be made available for free to members of the www.siliconinvestor.com and www.investorshub.com online communities. Investor's Hub boasts nearly 1.5 million page views per day alone and has more of a smallcap focus while Silicon Investor tends to be more blue chip in flavor and is the better-known brand.
Maxim Pharmaceuticals Announces Publication of Two Manuscripts Describing Pre-Clinical Anticancer Activity in Novel Class of Microtubule Inhibitors
SAN DIEGO, Dec. 1, 2004 (PRIMEZONE) -- Maxim Pharmaceuticals (Nasdaq:MAXM) (SSE:MAXM) announced today the publication of two manuscripts in the Journal of Molecular Cancer Therapeutics (Mol Cancer Ther 2004 3: pp. 1365-1374 and 1375-1384) describing Maxim's MX116407 anticancer drug candidate as part of a novel class of microtubule inhibitors with vascular targeting activity. The manuscripts characterize MX116407 as a potent caspase activator with strong antitumor activity in pre-clinical in vitro and in vivo studies. MX116407 appeared highly effective in mouse tumor models, producing tumor necrosis at doses that correspond to only 25% of the maximum tolerated dose. Moreover, in combination treatment, MX116407 significantly enhanced the antitumor activity of the chemotherapeutic agent cisplatin, resulting in tumor-free animals.
Titan General Holdings Inc
Titan General Holdings, Inc. Promotes Executive Curtis Okumura
FREMONT, Calif., Dec. 1, 2004 (PRIMEZONE) -- Titan General Holdings, Inc. (OTCBB:TTGH) ("Titan" or "Company") is proud to announce that Curtis K. Okumura was appointed President of the Company, effective as of December 16, 2004. Mr. Curtis, who is 41 years old, has served as General Manager of the Company's subsidiary, Titan PCB West since August 2001. From 2000 to 2001, Mr. Okumura served as General Manager of Circuit Link, Inc., a printed circuit board manufacturer. From 1985 to 2000, Mr. Okumura served in various capacities, including as an engineering manager for Data Circuit Systems, Inc. Mr. Okumura has an education in Business Administration from San Jose State University and Ohlone College.
Atlantis Business Development Corporation, Inc.
Atlantis Business Development Corporation Announces Payment to IRS
RED BANK, N.J., Dec. 1, 2004 (PRIMEZONE) -- Atlantis Business Development Corporation (OTCBB:ATBD) announced today that on November 19th a payment in the amount of $94,500.00 was made to the Internal Revenue Service on Atlantis's behalf. Atlantis's auditor, Bagel Josephs, negotiated this settlement between the IRS and ATBD (which was approved on September 6, 2004) and made the requisite payment. Having paid out this $94,500.00 to the IRS, ATBD's liabilities will reflect a reduction of $288,000.00.
Discovery Laboratories, Inc.
Discovery Labs to Present at Harris Nesbitt 4th Annual Focus on Healthcare Conference
WARRINGTON, Pa., Dec. 1, 2004 (PRIMEZONE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) today announced that Robert J. Capetola, Ph.D., President and Chief Executive Officer of Discovery, will present an update on the Company's recent progress and upcoming milestones to the investment community during the 4th Annual Focus on Healthcare Conference sponsored by Harris Nesbitt. The conference is being held at the Metropolitan Club in New York. Dr. Capetola will be presenting at 10:15 a.m. on Wednesday, December 8, 2004. The conference will feature presentations from senior executives of 50 leading and emerging healthcare companies and focus on biotechnology, life sciences, medical technology and pharmaceuticals.
S3 Investment Company, Inc.
S3 Investment Company CEO Interview Conducted by WallSt.net
TEMECULA, Calif., Dec. 1, 2004 (PRIMEZONE) -- S3 Investment Company (OTCBB:SEIH) today announced that CEO and Chairman Chris Bickel has participated in an interview by WallSt.net. The interview covers the company's recently announced agreement to acquire SINO UJE and S3 Investments' short, medium and long-term expectations for its investment portfolio. To hear the entire interview, visit http://www.wallst.net and either by locate the company's ticker symbol (SEIH) on the left hand column under the OTCBB exchange, or by entering the ticker symbol (SEIH) in the Audio Search window at the top of the page.
Media Classics Group International Inc.
Media Classics in Joint Production Agreement for 'In Their Own Words,' a Series of Audio and Video Documentary Titles
PALM SPRINGS, Calif., Dec. 1, 2004 (PRIMEZONE) -- Media Classics Group International Inc. (Pink Sheets:MCGI) announced that it has reached a definitive agreement to jointly produce the "In Their Own Words" series of documentary audio books and video books that will be produced and distributed by Re-Q Inc., a Beverly Hills based entertainment production and licensing company. The first title "RFK" features the events surrounding the assignation of Robert F. Kennedy. Features include interviews with then Chief of Police, Ed Davis, and his assistant, Chief Darrel Gates, as well as some of the best footage of Surhan Surhan.